Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Opticol Corp
Original Assignee
Opticol Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Opticol CorpfiledCriticalOpticol Corp
Priority to ES477409ApriorityCriticalpatent/ES477409A1/es
Publication of ES477409A1publicationCriticalpatent/ES477409A1/es
Un método para la fabricación de lentes de contacto blandas, que comprende tratar una fuente de colágeno para extraer de ella el colágeno, convertir el colágeno extraído en un ge lamoso de colágeno transparente, que tiene una concentración de colágeno de 1,0% en peso a 30,0% en peso, conformar un cuerpo de lente de contacto a partir de dicho gel y reticular el cuerpo de lente.
ES477409A1979-02-021979-02-02Un metodo para la fabricacion de lentes de contacto blandas.
ExpiredES477409A1
(es)
Verfahren zur herstellung von 4'deoxydaunorubicin und 4'-deoxydoxorubicin, sowie 4'-epi-4'-trifluormethyl-sulfonyloxy-ntrifluoracetyldaunorubicin.
Verfahren zur herstellung von 1-alkadien-2,4-yl-2-hidroxymethyl-3,4,5-trimydroxypiperidinen mit wirkung uber die kohlehydraten und/oder fettwechsel und von diesen verbindungen enthaltenden pharmazeutischen und/oder tierartzleichen praparaten
Process for the preparation of o-methyl-n-cyclohexyl-2,5-dimethyl-furan-3-hydroxamic acid,n-cyclohexyl-n-methoxyacetoacetamide employed as intermediate therein and its preparation